Abstract
The results of studies performed in the author’s laboratory are surveyed, with particular emphasis on demonstrating the value of a multidisciplinary synthetic modeling approach for discovering new and unusual chemistry helpful for understanding the properties of the active sites of copper proteins or assessing the feasibility of mechanistic pathways they might follow during catalysis. The discussion focuses on the progress made to date toward comprehending the nitrite reductase catalytic site and mechanism, the electronic structures of copper thiolate electron transfer centers, the sulfido-bridged “CuZ” site in nitrous oxide reductase, and the processes of dioxygen binding and activation by mono- and dicopper centers in oxidases and oxygenases.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Copper proteins are involved in numerous processes that impact life and the environment [1]. The copper sites within this large class of metallobiomolecules function in a variety of ways, including transferring electrons over variable distances at divergent rates and potentials, binding and activating dioxygen for respiration and for oxidations of substrates in metabolically important reactions, and reducing nitrogen oxides in processes that are critical components of the global nitrogen cycle. Significant differences among the geometric, electronic structural, and spectroscopic features of copper protein active sites reflect a structural diversity that accompanies their functional variability. Despite extensive research, the understanding of structure–function relationships at the molecular level is incomplete, however, and many questions remain unanswered concerning the detailed mechanisms and fundamental chemistry underlying copper-mediated processes in biology. Such specific knowledge of bioinorganic copper chemistry also informs studies of other metal-containing biosites and ultimately will enable intelligent control of vital enzymatic and other catalytic reactions.
We are interested in obtaining fundamental chemical insights into copper protein active-site structure and mechanisms of action through the synthetic modeling approach. As described in more detail elsewhere [2–4], this approach entails using ligand design principles and appropriate control of reaction conditions to prepare low molecular weight complexes that resemble the targeted metalloprotein active site, either in a resting state or as a reactive intermediate. Detailed characterization of the new molecules by structural, spectroscopic, and theoretical techniques can then provide deep electronic structural insights potentially applicable to the biological systems. In addition, studies using synergistic experiments and theoretical calculations to examine the reactivity of the synthetic compounds and the mechanisms of their reactions can reveal new types of reaction pathways relevant to metalloenzyme catalysis. Finally, in the course of following the synthetic modeling approach, novel molecules may be synthesized that may be of intrinsic interest from a fundamental chemistry standpoint, irrespective of their biological relevance.
In this minireview, I present an overview of the results from my laboratory of research we have performed involving the use of synthetic methods to understand copper protein active-site chemistry. As a result, the discussion will be somewhat narrowly focused, yet hopefully it will nonetheless serve to illustrate what one may learn about copper protein active-site structure and function through the synthetic modeling approach. Broader perspectives more inclusive of the work of others in this dynamic research area are available in numerous comprehensive reviews, a limited selection of which is listed here [5–11].
Copper nitrite and copper nitrosyl complexes: models of the nitrite reductase catalytic site
Copper nitrite reductase (Cu NiR) plays a key role in biological denitrification [9, 12–14], an environmentally significant process whereby bacteria use nitrogen oxides as terminal electron acceptors in respiration and produce gaseous products (Eq. 1). The initially reported X-ray crystal structure [15] revealed that Cu NiR contains a type 1 electron transfer site connected via a His-Cys bridge to a copper ion ligated by three His imidazolyls and a water molecule (Fig. 1). Substrate (NO2 −) is reduced at the His3Cu center, with electrons transferred from the type 1 Cu via the His-Cys bridge [16–18]. Our modeling efforts were inspired by a report by Hulse et al. [19] in which it was stated that Cu NiR “produces N2O via a bound nitrosyl intermediate, E-NO+; this is presumably a cuprous nitrosyl, Cu+–NO+, of which there are no structurally characterized synthetic examples.” We therefore decided to target a copper nitrosyl complex for synthesis and characterization, and found success by treating Cu(I) complexes of sterically hindered, facially coordinating tris(pyrazolyl)hydroborate ligands with NO (Fig. 2) [20–22]. End-on coordination of NO was confirmed by X-ray crystallography, and through detailed spectroscopic studies informed by theoretical calculations, insights into the electronic structure of the novel [CuNO]11 unit were obtained (electron counting formalism described in Ref. [23]). Notably, the results indicated that this unit is best described as Cu(I)–NO• rather than Cu(II)–NO−. The binding of NO to the Cu(I) center is relatively weak, and when supporting ligands with substituents smaller than t-butyl were used, the nitrosyl complex reacted further with NO to yield a Cu(II)–NO2 − complex and N2O (Eq. 2) [24]. Mechanistic studies of this disproportionation reaction [22, 24] showed that attack of NO onto the copper nitrosyl complex is rate-determining. Identification of this facile process in the synthetic system suggested that a similar reaction may occur in the enzyme, providing one possible rationale for N2O formation by Cu NiR under conditions of high concentrations of NO.
It is generally recognized that nitrite reduction by NiR involves coordination of NO2 − at the His3Cu site followed by protonation events that trigger loss of H2O to yield a labile copper nitrosyl, which then releases NO [12–14]. The detailed molecular motions involved have been the subject of debate, however. X-ray crystallographic [25] and spectroscopic [26] studies showed that NO2 − binds to the Cu(II) form of the active site via its O atoms, which raises the question of how an N-bound nitrosyl can subsequently be generated. One possibility is that reduction of the Cu center results in isomerization of the nitrite to an N-bound form. Precedent for this idea came from synthetic work from our laboratory [27, 28], wherein a mononuclear Cu(I)–NO2 − complex supported by a biomimetic tridentate N-donor ligand (1,4,7-triisopropyltriazacylononane [29]) was shown to exhibit η 1-N coordination (Fig. 3) and to release NO upon treatment with acids (HOAc) or acid equivalents (trimethylsilyl trifluoromethanesulfonate, TMSOTf). This sequence has since been identified with other supporting ligand systems [30]. Another possible least-motion pathway for an O-bound nitrite to generate NO is for protonation and water loss to yield a side-on “η 2” nitrosyl adduct, which in transition metal chemistry is typically only a metastable species [31]. Such an adduct has recently been identified in Cu NiR by X-ray crystallography [32, 33], however, and has been examined by theoretical calculations at both the [CuNO]10 and [CuNO]11 redox levels [34]. Still, it remains unknown in synthetic copper chemistry, and thus is a tempting target for future research.
Copper thiolate complexes: models of the type 1 and “CuA” electron transfer sites
The type 1 site in Cu NiR is a member of a large class of copper centers in biology that function as electron transfer reagents [35]. Thiolate ligation is a common feature of such centers, which may be subdivided into two types according to their nuclearity. The “CuA” site is dinuclear, as determined originally from electron paramagnetic resonance (EPR) studies that were interpreted to indicate a mixed-valent fully delocalized ground state [36, 37], and later from X-ray crystallography (Fig. 4a) (the first reports of the structure of CuA in cytochrome c oxidase are in Refs. [38, 39]. Type 1 sites are mononuclear and have in common a short, covalent copper thiolate bond, yet their particular coordination geometries differ significantly. This may be illustrated by comparing the distorted tetrahedral Cu NiR type 1 moiety (Fig. 1) with the three-coordinate and trigonal bipyramidal sites of fungal laccase and azurin, respectively (Fig. 4b, c). A longstanding topic of research has been to understand how these structural variations contribute to the spectroscopic properties and electron transfer reactivity of these sites (e.g., rates and potentials) [35, 40–44]. Efforts to address this goal via the synthetic modeling approach have consumed inorganic chemists for decades [11, 45], a key success being the isolation of the compounds TpCuSR [Tp is tris(3,5-diisopropylpyrazolyl)hydroborate, R is CPh3 or C6F5] that were found to exhibit the appropriately short Cu–SR bond and biomimetic EPR and UV–vis spectroscopic properties [46–48]. We sought structural variants for attaining closer structural fidelity to the natural sites and for uncovering structure–function relationships, in particular synthetic analogs of the three-coordinate fungal laccase site (notable owing to the presence of Cu(II) in an unprecedented low coordination number) and molecules that contain the typical thiolate/thioether ligation (cf. Cu NiR).
The synthesis of the first example of a three-coordinate Cu(II) complex, LCuCl (L is β-diketiminate ligand), laid the groundwork for the preparations of the targeted Cu(II) thiolate complexes (Fig. 5a, b) [49, 50]. The key to the syntheses was the use of the sterically hindered isopropyl-substituted version of L; less hindered variants yielded dimeric precursors [LCuCl]2 that failed to provide stable thiolate derivatives [51]. The compounds LCuSR (R is t-Bu or o-dimethylphenyl) and LCu(SC(Ph)2CH2SMe) are accurate structural biomimics insofar as their coordination geometries agree closely with those of the fungal laccase site or the Cu NiR site, respectively. Most illuminating, however, were detailed spectroscopic studies of LCuSR that focused on drawing comparisons with TpCuSR and the fungal laccase site [52, 53]. Notable among the many conclusions drawn from these studies was the finding that the key redox orbital in LCuSR (Fig. 5c) closely resembles that determined for the Tp complex and the protein, but with subtle differences due to the especially strong electron donating character of the β-diketiminate ligand. In short, through an enhanced trans influence the β-diketiminate increases the d-orbital splitting and weakens the Cu d + S pπ interaction relative to the splitting and interaction of the other centers. This property of the β-diketiminate underlies a reduction potential of −0.18 V versus the normal hydrogen electrode that is drastically lower than that of the fungal laccase site (more than +0.7 V) and also has repercussions in Cu/O2 chemistry (see later).
Our efforts to build a model of the dinuclear CuA site were initially stimulated by a lively debate over the nature of this center at a conference attended in 1992 (the proceedings are published in Ref. [54]), but after its bis(μ-thiolato)dicopper structure had been confirmed [38, 39], further impetus was provided by the need to understand the basis for its unusual mixed-valence delocalized “Cu(1.5)Cu(1.5)” electronic structure [55]. Significant synthetic efforts culminated in the successful preparation of a complex that mimicked key aspects of CuA, in particular a [Cu2(SR)2]+ core with full valence delocalization by EPR spectroscopy (Fig. 6) [56]. Nonetheless, structural differences between the model and the biosite resulted in important and informative disparities in spectroscopic properties [41, 57–59]. For example, the Cu–Cu distance in the model is 2.9306(9) Å, significantly longer than in CuA (approximately 2.4 Å), and the model contains two strongly bound terminal ligand N donors, whereas CuA has only one (in addition to a much more weakly coordinating group). While similar Cu–S bond covalencies in the model complex and CuA were indicated by S K-edge and Cu L-edge X-ray absorption spectroscopy (XAS) [59], the mixed-valent ψ→ψ* transition energies differed by approximately 7,800 cm−1 (CuA>model). These results were interpreted to provide quantitative support for the previously suggested and unique Cu–Cu bonding interaction in CuA [60] that is absent in the model complex. The calculated highest occupied molecular orbitals (HOMOs) for the model complex and CuA (Fig. 6) illustrate the different metal–metal interactions, which were argued to arise in large part from differences in the terminal ligand geometries [58]. Importantly, in this work the most significant insights into the electronic structure of the biosite came from analysis of key differences between it and the model complex. Thus, comparative studies on inexact models of a metalloprotein active site may sometimes be especially informative.
Copper sulfide chemistry: toward models of the nitrous oxide reductase catalytic center (“CuZ”)
The reduction of N2O to N2 during denitrification is catalyzed by nitrous oxide reductase (N2OR) [61, 62], which contains two types of copper sites, a CuA-type center proposed to perform an electron transfer function, and a catalytic cluster (“CuZ”) recently shown by X-ray crystallography [63, 64] and resonance Raman spectroscopy [65, 66] to contain four Cu ions bridged by a μ 4-sulfido moiety (Fig. 7). The fully reduced Cu(I)4 form of the cluster has been proposed to bind and reduce N2O via pathways supported by theoretical calculations, although more oxidized forms have been identified and may be catalytically relevant [62, 67–72]. Impetus for synthetic modeling of CuZ is provided by its structural novelty and the provocative nature of the mechanisms proposed for its activity. While Cu(I) sulfido species have been reported with supporting soft, abiological donor ligands (e.g., phosphines) [73], little is known about copper–sulfur chemistry with N-donor ligands akin to the histidine imidazolyl donors present in CuZ. Thus, we are actively exploring fundamental aspects of copper–sulfur chemistry using such supporting ligands, with the ultimate goal of constructing accurate models of CuZ with which to perform detailed comparative spectroscopic and reactivity studies.
So far, these explorations have led to the isolation of copper complexes of varying nuclearity that feature sulfur in multiple redox forms, including S2 2−, S2 •−, and S2− [74–76]. Using copper-containing starting materials supported by anionic β-diketiminate or anilido-imine ligands, a class of (μ-η 2:η 2-S2 2−)dicopper(II) complexes was prepared, one member of which is shown in Fig. 8a. Related (μ-S2 2−)dicopper(II) compounds with tri- or tetradentate N-donor ligands have been reported [77–80].
A different reaction course was followed, however, when Cu(I) complexes of the neutral bidentate N donors N,N,N′,N′-tetramethylethylenediamine (TMEDA) or N,N,N′,N′-tetramethylcyclohexane-1,2-diamine (TMCHD) were treated with S8 [75]. In this case, we isolated novel clusters comprising [Cu3(μ-S)2]3+ cores with SbF6 − or PF6 − counterions (Fig. 8b). These clusters model attributes of CuZ, insofar as the (μ-sulfido)tricopper subunit resembles the portion of CuZ comprising Cu2, Cu3, Cu4, and S (Fig. 7). Interestingly, while a previously reported analog with a [Cu3(μ-O)2]3+ core is valence localized [81, 82], with one Cu(III) and two ferromagnetically coupled Cu(II) ions that exhibit divergent metal–ligand bond distances, the [Cu3(μ-S)2]3+ core exhibits complete delocalization, as indicated by EPR spectroscopy (10-line Cu-hyperfine in g=4 signal at X-band at 10 K) and X-ray diffraction (local D 3h cluster symmetry with equivalent metal–ligand bond distances). Theoretical calculations rationalize these differences in electronic delocalization by invoking σ-type antibonding interactions between the S p orbitals that underlie an inversion in the frontier molecular orbital energy ordering relative to that of the oxo-bridged cluster [75].
More recently, we found that when S8 was added to the Cu(I) complex of TMEDA having a CF3SO3 − counterion, a compound with a novel [Cu2(S2)2]2+ core and axially coordinated CF3SO3 − groups is generated (Fig. 8c) [76]. On the basis of structural data (cf. S–S=1.95 Å) and resonance Raman spectroscopy [ν(S–S)=613 cm−1], the core is best formulated as having Cu(II) ions linked by S2 •− bridges rather than Cu(III) ions with S2 2− units. Apparently, widely varying copper–sulfur core topologies and oxidation levels can result from rather subtle changes in N-donor ligands and/or counterions, and we are therefore inspired to further explore Cu–S chemistry with the ultimate goal of modeling the unique CuZ site.
Peroxodicopper and bis(μ-oxo)dicopper complexes: models of oxygenase intermediates
Understanding how dioxygen is bound and activated at multicopper sites in proteins such as hemocyanin [83], the multicopper oxidases [84–86], particulate methane monooxygenase [85, 87], and tyrosinase [84, 85, 88] has been a longstanding objective of synthetic modeling studies [5–10, 89–91]. Inspired by the pioneering work of Karlin [92] and Kitajima et al. [93], who were the first to structurally define trans-1,2-peroxodicopper and μ-η 2:η 2-peroxodicopper complexes, respectively, we examined the low-temperature oxygenations of Cu(I) complexes of substituted 1,4,7-triazacyclononane ligands [94]. In the course of this work, we isolated and characterized bis(μ-oxo)dicopper(III) complexes and showed that in one case (using a supporting ligand with i-Pr substituents) this species can rapidly equilibrate with a μ-η 2:η 2-peroxodicopper isomer [95], thus illustrating how the O–O bond in dioxygen may be reversibly broken and formed (Fig. 9). These results, as well as those of others that have demonstrated the ubiquity of the bis(μ-oxo)dicopper core and the generality of this reversible isomerization, have been reviewed recently elsewhere [6, 7, 90]. Here, I focus on a key mechanistic question that consideration of these results raised [96]: Which is the active oxidant in tyrosinase, the observed μ-η 2:η 2-peroxodicopper intermediate or a derived bis(μ-oxo) isomer? While only studies of the enzyme itself can directly address this question, through the synthetic modeling approach one can determine what is chemically possible; that is, whether or not either isomer is capable of performing the critical tyrosinase oxidation step, hydroxylation of an aromatic ring (e.g., phenol).
A number of studies have shown that the μ-η 2:η 2-peroxodicopper unit can hydroxylate aromatic rings through an electrophilic mechanism [7, 90, 91, 97, 98]. Of these studies, perhaps the most definitive is the extensive examination of the hydroxylation of the meta-xylyl bridge of a binucleating pyridyl-amine ligand upon decay of a μ-η 2:η 2-peroxodicopper complex [97]. On the other hand, when bis(μ-oxo)dicopper complexes are allowed to decompose, supporting N-donor ligand substituent C–H bonds positioned near the bridging oxygen atoms are attacked, leading to N-dealkylation via a hydrogen atom abstraction pathway that is typical for such bis(μ-oxo) cores [7]. In order to avoid this type of process and to assess the capability of the bis(μ-oxo)dicopper unit to attack an arene instead, we designed a bidentate ligand which would favor bis(μ-oxo)dicopper complex formation and position an arene near the bridging oxygen atoms, with other substituent C–H bonds oriented such that they would not be as susceptible to attack [99, 100]. Upon low-temperature oxygenation of the Cu(I) complex of this new ligand, only spectroscopic features of a bis(μ-oxo)dicopper complex were observed, and upon warming and removal of the copper ions, products corresponding to hydroxylation of the arene were identified (Fig. 10). The hydroxylation product yields and rates of formation increased with the electron donating capabilities of the substituents X and no H/D kinetic isotope effect was observed, consistent with an electrophilic aromatic substitution pathway.
While these results seem to demonstrate that the bis(μ-oxo)dicopper core is indeed capable of hydroxylating an appropriately positioned aromatic ring, they do not constitute proof for this idea, for one cannot rule out arene attack by a small amount of a reactive μ-η 2:η 2-peroxodicopper isomer formed in a rapid pre-equilibrium step. Arguments against the viability of a bis(μ-oxo)dicopper intermediate in tyrosinase have been made on the basis of theoretical calculations [101], but methodological issues that complicate attempts to accurately determine the relative energies of μ-η 2:η 2-peroxodicopper and bis(μ-oxo)dicopper isomers have been raised recently that render these conclusions suspect [102, 103]. In a particularly relevant report [104], a phenolate adduct to a bis(μ-oxo)dicopper complex was identified at low temperature and found to yield phenol hydroxylation products (catechol and o-quinone) upon warming. Theoretical calculations support an intramolecular process involving attack of the bis(μ-oxo)dicopper core lowest unoccupied molecular orbital on the phenolate ligand HOMO and, thus, the feasibility of oxidation of phenol by the bis(μ-oxo)dicopper core. Still, the possible involvement of a μ-η 2:η 2-peroxodicopper species cannot be ruled out definitively by experiment in this case either, so from a formal standpoint at least the question of which species is the active oxidant in tyrosinase remains unresolved.
Monocopper–dioxygen adducts: modeling monocopper oxidases and oxygenases
The binding and activation of dioxygen by a single copper site are central steps in the mechanisms of several biologically significant metalloenzymes [105, 106], including the amine oxidases, dopamine β-monooxygenase (DβM) [107], and peptidylglycine α-hydroxylating monooxygenase (PHM) [108]. Extensive studies of DβM and PHM in particular have led to the proposal that a 1:1 Cu/O2 adduct is responsible for attacking the target C–H bond of their respective substrates [109, 110]. This adduct has been suggested to feature O2 coordinated in η 1 “end-on” fashion to “CuM,” the copper site ligated by two His imidazoles and a Met thioether, on the basis of an X-ray crystal structure of PHM determined by using a slow-reacting substrate (Fig. 11) [111]. Many questions about the structural aspects and functional role(s) of this and other postulated 1:1 Cu/O2 adducts in proteins have stimulated extensive efforts to isolate and characterize such species synthetically [7, 106]. Such efforts have been complicated by the tendency for 1:1 Cu/O2 adducts to react rapidly with a second Cu(I) ion to yield relatively stable peroxodicopper or bis(μ-oxo)dicopper compounds. At the outset of our work, this reaction had been inhibited successfully in only one instance to yield an η 2 “side-on” complex supported by a sterically hindered tris(pyrazolyl)hydroborate ligand (Fig. 12a) [112]. Structural, spectroscopic, and theoretical studies showed that this adduct is best formulated as a Cu(II) superoxide [113], notwithstanding an apparently underestimated O–O bond distance (1.22 Å) in the reported X-ray structure [114].
We found that bis(μ-oxo)dicopper complexes were generated upon reaction of Cu(I) complexes of sterically undemanding β-diketiminates with O2 at low temperature [115, 116]. On the other hand, when more sterically hindered β-diketiminates or related anilido-imine ligands were used, the reactions yielded isolable 1:1 Cu/O2 adducts that have been extensively characterized (Fig. 12b) [115, 117–119]. The combined results support significant Cu(III) peroxide character for these adducts. Key data include (1) an O–O bond distance determined to be 1.392(2) Å from a high-resolution X-ray structure that falls between distances characteristic of coordinated superoxide and peroxide ligands [119], (2) a Cu K-edge XAS spectrum with a 1s→3d pre-edge transition energy (approximately 3,981 eV) essentially identical to those of bis(μ-oxo)dicopper compounds [118], and (3) corroborating theoretical results that show, for example, orbital occupation numbers from multiconfigurational CASPT2 calculations for the Cu/O2 moiety that are closer to d 8/O2 2− than to d 9/O2 − [119, 120]. These findings make sense in view of the powerful electron-donating capabilities of the β-diketiminate and anilido-imine ligands, which stabilize the Cu(III) state and effectively “push” electron density onto the coordinated dioxygen unit.
Considerable insight into the mechanism of formation of the 1:1 Cu/O2 adducts from the reaction of the Cu(I) precursor LCu(NCR) (L is β-diketiminate, R is alkyl or aryl) with O2 was obtained through synergistic low-temperature stopped-flow kinetics studies and theoretical calculations [118]. In brief, the kinetics data support a dual pathway mechanism involving a second-order associative path wherein O2 binds and nitrile then dissociates (pathway A; Fig. 13), as well as a competing path with a zero-order dependence on O2 concentration that involves prior displacement of nitrile by tetrahydofuran (THF) solvent (solvolysis) followed by a rapid associative substitution by O2 (pathway B). The transition states for each pathway were calculated by density functional theory, revealing interesting differences in the O2 binding geometries to the ligand being displaced that depend on the nature of the solvent (end-on for THF vs. asymmetric side-on for CH3CN, shown in Fig. 13). Overall, the reaction is calculated to be highly exergonic, in good agreement with the experimental finding that the binding of O2 is irreversible, such that argon purging removes excess O2 without perturbing the spectroscopic features of the 1:1 Cu/O2 adduct. We have taken advantage of this irreversible binding behavior by using the adduct as a synthon for the stepwise construction of bis(μ-oxo)dimetal complexes that feature different metals (cf. Cu–Ni [121]) or different ligands on each metal [117]. Further applications of this methodology for the synthesis of novel heterobimetallic compounds or higher nuclearity models of multicopper protein active sites are currently under investigation.
More recently, we have probed the role of the Met thioether ligand in PHM by incorporating a thioether substituent into the β-diketiminate framework (Fig. 14) [122]. Copper(I) complexes of the new ligands react with O2 at low temperature to yield 1:1 Cu/O2 adducts that we postulate on the basis of spectroscopic data and theoretical calculations have similar side-on Cu(III) peroxo structures to those of the parent ligand system lacking the thioether. Yet, while the structure of the 1:1 Cu/O2 adduct is not perturbed by the thioether, the O2 binding equilibrium is affected, as evidenced by conversion of the adduct to a bis(μ-oxo)dicopper complex upon purging with argon. The bis(μ-oxo)dicopper species forms via loss of O2 from the 1:1 Cu/O2 adduct to yield a Cu(I) species that is then trapped by remaining adduct. Thus, the thioether appears to decrease the equilibrium constant for O2 binding to the copper ion by decreasing the rate of O2 coordination, increasing the rate of O2 dissociation, or both. These results provide precedence for the hypothesis of similar influences of the Met ligand on the binding of O2 to the CuM site in DβM and PHM [109, 110].
Conclusions and perspective
A deeper understanding of the structures, properties, and reactivity of a range of copper protein active-site species has been obtained through studies of model complexes synthesized using relatively simple supporting ligands. Central to these studies has been the characterization of new copper complexes using multiple complementary and synergistic techniques, often in collaboration with experts in the fields of advanced spectroscopy, rapid kinetics, and theory. In the end, the value of this approach lies in the ability to discover new and unusual chemistry that can rationalize observed features of the metalloproteins themselves or, in special cases, indicate a new way of thinking about how a metalloenzyme might work. Perhaps most importantly, discoveries of new synthetic model chemistry raise new questions that stimulate further research. In this regard, many targets remain for future synthetic studies. These include a (μ-sulfido)tetracopper cluster model of CuZ in N2OR, tricopper/O2 species with which to test the feasibility of intermediates postulated for the multicopper oxidases, and a low-coordinate monocopper complex featuring end-on O2 coordination like that postulated as the reactive species in oxygenases like PHM. The exciting prospects for gaining new knowledge of copper protein properties and for discovering novel chemistry in pursuit of these and other related objectives provide a basis for continued confidence in the utility of the synthetic modeling approach in bioinorganic chemistry.
References
Kaim W, Rall J (1996) Angew Chem Int Ed Engl 35:43–60
Ibers JA, Holm RH (1980) Science 209:223–235
Karlin KD (1993) Science 261:701–708
Holm RH, Solomon EI (2004) Chem Rev 104:347–348
Kitajima N (1992) Adv Inorg Chem 39:1–77
Mirica LM, Ottensaelder X, Stack TDP (2004) Chem Rev 104:1013–1045
Lewis EA, Tolman WB (2004) Chem Rev 104:1047–1076
Kopf M-A, Karlin KD (2000) In: Meunier B (ed) Biomimetic oxidations catalyzed by transition metal complexes. Imperial College Press, London, pp 309–362
Wasser IM, de Vries S, Moënne-Loccoz P, Schröder I, Karlin KD (2002) Chem Rev 102:1201–1234
Itoh S, Fukuzumi S (2002) Bull Chem Soc Jpn 75:2081–2095
Bouwman E, Driessen WL, Reedijk J (1990) Coord Chem Rev 104:143–172
Averill BA (1996) Chem Rev 96:2951–2964
Suzuki S, Kataoka K, Yamaguchi K (2000) Acc Chem Res 33:728–735
Eady RR, Hasnain SS (2004) In: McCleverty JA, Meyer TJ (eds) Comprehensive coordination chemistry II, vol 8. Elsevier, Amsterdam, pp 759–786
Godden JW, Turley S, Teller DC, Adman ET, Liu MY, Payne WJ, LeGall J (1991) Science 253:438–442
Suzuki S, Kohzuma T, Deligeer, Yamaguchi K, Nakamura N, Shidara S, Kobayashi K, Tagawa S (1994) J Am Chem Soc 116:11145–11146
Farver O, Eady RR, Abraham ZHL, Pecht I (1998) FEBS Lett 436:239–242
Suzuki S, Deligeer, Yamaguchi K, Kataoka K, Kobayashi K, Tagawa S, Kohzuma T, Shidara S, Iwasaki H (1997) J Biol Inorg Chem 2:265–274
Hulse CL, Averill BA, Tiedje JM (1989) J Am Chem Soc 111:2322–2323
Carrier SM, Ruggiero CE, Tolman WB, Jameson GB (1992) J Am Chem Soc 114:4407–4408
Ruggiero CE, Carrier SM, Antholine WE, Whittaker JW, Cramer CJ, Tolman WB (1993) J Am Chem Soc 115:11285–11298
Schneider JL, Carrier SM, Ruggiero CE, Young VG Jr, Tolman WB (1998) J Am Chem Soc 120:11408–11418
Enemark JH, Feltham RD (1974) Coord Chem Rev 13: 339–406
Ruggiero CE, Carrier SM, Tolman WB (1993) Angew Chem Int Ed Engl 33:895–897
Murphy MEP, Turley S, Adman ET (1997) J Biol Chem 272:28455–28460
Veselov A, Olesen K, Sienkiewicz A, Shapleigh JP, Scholes CP (1998) Biochemistry 37:6095–6105
Halfen JA, Tolman WB (1994) J Am Chem Soc 116:5475–5476
Halfen JA, Mahapatra S, Wilkinson EC, Gengenbach AJ, Young VG Jr, Que L Jr, Tolman WB (1996) J Am Chem Soc 118:763–776
Haselhorst G, Stoetzel S, Strassburger A, Walz W, Wieghardt K, Nuber B (1993) J Chem Soc Dalton Trans 83–90
Yokoyama H, Yamaguchi K, Sugimoto M, Suzuki S (2005) Eur J Inorg Chem 1435–1441
Coppens P, Novozhilova I, Kovalevsky A (2002) Chem Rev 102:861–883
Tocheva EI, Rosell FI, Mauk AG, Murphy MEP (2004) Science 304:867–870
Antonyuk SV, Strange RW, Sawers G, Eady RR, Hasnain SS (2005) Proc Natl Acad Sci USA 102:12041–12046
Wasbotten IH, Ghosh A (2005) J Am Chem Soc (in press)
Lu Y (2004) In: McCleverty JA, Meyer TJ (eds) Comprehensive coordination chemistry II, vol 8. Elsevier, Amsterdam, pp 91–122
Kroneck PMH, Antholine WA, Riester J, Zumft WG (1988) FEBS Lett 242:70–74
Antholine WE, Kastrau DHW, Steffens GCM, Buse G, Zumft WG, Kroneck PMH (1992) Eur J Biochem 209:875–881
Iwata S, Ostermeier C, Ludwig B, Michel H (1995) Nature 376:660–669
Tsukihara T, Aoyama H, Yamashita E, Tomizaki T, Yamaguchi H, Shinzawa-Itoh K, Nakashima R, Yaono R, Yoshikawa S (1995) Science 269:1069–1074
Gray HB, Malmstrom BG, Williams RJP (2000) J Biol Inorg Chem 551–559
Randall DW, Gamelin DR, LaCroix LB, Solomon EI (2000) J Biol Inorg Chem 5:16–19
Dennison C (2005) Dalton Trans 3436–3442
Yanagisawa S, Dennison C (2005) J Am Chem Soc 127:16453–16459
Solomon EI, Szilagyi RK, DeBeerGeorge S, Basumallick L (2004) Chem Rev 104:419–458
Mandal S, Das G, Singh R, Shukla R, Bharadwaj PK (1997) Coord Chem Rev 160:191–235
Kitajima N, Fujisawa K, Moro-oka Y (1990) J Am Chem Soc 112:3210–3212
Kitajima N, Fujisawa K, Tanaka M, Moro-oka Y (1992) J Am Chem Soc 114:9232–9233
Randall DW, George SD, Hedman B, Hodgson KO, Fujisawa K, Solomon EI (2000) J Am Chem Soc 122:11620–11631
Holland PL, Tolman WB (1999) J Am Chem Soc 121:7270–7271
Holland PL, Tolman WB (2000) J Am Chem Soc 122:6331–6332
Spencer DJE, Reynolds AM, Holland PL, Jazdzewski BA, Duboc-Toia C, Pape LL, Yokota S, Tachi Y, Itoh S, Tolman WB (2002) Inorg Chem 41:6307–6321
Randall DW, DeBeer S, Holland PL, Hedman B, Hodgson KO, Tolman WB, Solomon EI (2000) J Am Chem Soc 122:11632–11648
Chowdhury A, Penteanu LA, Holland PL, Tolman WB (2002) J Phys Chem B 106:3007–3012
Karlin KD, Tyeklár Z (eds) (1993) Bioinorganic chemistry of copper. Chapman & Hall, New York
Farrar JA, Neese F, Lappalainen P, Kroneck PMH, Saraste M, Zumft WG, Thomson AJ (1996) J Am Chem Soc 118:11501–11514
Houser RP, Young VG Jr, Tolman WB (1996) J Am Chem Soc 118:2101–2102
Williams KR, Gamelin DR, LaCroix LB, Houser RP, Tolman WB, Mulder TC, de Vries S, Hedman B, Hodgson KO, Solomon EI (1997) J Am Chem Soc 119:613–614
Gamelin DR, Randall DW, Hay MT, Houser RP, Mulder TC, Canters GW, de Vries S, Tolman WB, Lu Y, Solomon EI (1998) J Am Chem Soc 120:5246–5263
George SD, Metz M, Szilagyi RK, Wang H, Cramer SP, Lu Y, Tolman WB, Hedman B, Hodgson KO, Solomon EI (2001) J Am Chem Soc 123:5757–5767
Blackburn NJ, Barr ME, Woodruff WH, Ooost Jvd, de Vries S (1994) Biochemistry 33:10401–10407
Zumft WG (1997) Microbiol Rev 61:533–616
Chen P, Gorelsky SI, Ghosh S, Solomon EI (2004) Angew Chem Int Ed Engl 43:4132–4140
Brown K, Djinovic-Carugo K, Haltia T, Cabrito I, Saraste M, Moura JJG, Moura I, Tegoni M, Cambillau C (2000) J Biol Chem 275:41133–41136
Haltia T, Brown K, Tegoni M, Cambillau C, Saraste M, Mattila K, Djinovic-Carugo K (2003) Biochem J 369:77–88
Alvarez ML, Ai J, Zumft W, Sanders-Loehr J, Dooley DM (2001) J Am Chem Soc 123:576–587
Rasmussen T, Berks BC, Sanders-Loehr J, Dooley DM, Zumft WG, Thomson AJ (2000) Biochemistry 39:12753–12756
Chen P, Cabrito I, Moura JJG, Moura I, Solomon EI (2002) J Am Chem Soc 124:10497–10507
Chen P, DeBeer George S, Cabrito I, Antholine WE, Moura JJG, Moura I, Hedman B, Hodgson KO, Solomon EI (2002) J Am Chem Soc 124:744–745
Ghosh S, Gorelsky SI, Chen P, Cabrito I, Moura JJG, Moura I, Solomon EI (2003) J Am Chem Soc 125:15708–15709
Chan JM, Bollinger JA, Grewell CL, Dooley DM (2004) J Am Chem Soc 126:3030–3031
Rasmussen T, Brittain T, Berks BC, Watmough NJ, Thomson AJ (2005) Dalton Trans 3501–3506
Gorelsky SI, Ghosh S, Solomon EI (2006) J Am Chem Soc 128:278–290
Dehnen S, Eichhöfer A, Fenske D (2002) Eur J Inorg Chem 279–317
Brown EC, Aboelella NW, Reynolds AM, Aullón G, Alvarez S, Tolman WB (2004) Inorg Chem 43:3335–3337
Brown EC, York JT, Antholine WE, Ruiz E, Alvarez S, Tolman WB (2005) J Am Chem Soc 127:13752–13753
York JT, Brown EC, Tolman WB (2005) Angew Chem Int Ed Engl (in press)
Fujisawa K, Moro-oka Y, Kitajima N (1994) J Chem Soc Chem Commun 623–624
Helton ME, Chen P, Paul PP, Tyeklar Z, Sommer RD, Zakharov LN, Rheingold AL, Solomon EI, Karlin KD (2003) J Am Chem Soc 125:1160–1161
Chen P, Fujisawa K, Helton ME, Karlin KD, Solomon EI (2003) J Am Chem Soc 125:6394–6408
Helton ME, Maiti D, Zakharov LN, Rheingold AL, Porco JA Jr, Karlin KD (2006) Angew Chem Int Ed (early view)
Cole AP, Root DE, Mukherjee P, Solomon EI, Stack TDP (1996) Science 273:1848–1850
Root DE, Henson MJ, Machonkin T, Mukherjee P, Stack TDP, Solomon EI (1998) J Am Chem Soc 120:4982–4990
Magnus KA, Ton-That H, Carpenter JE (1994) Chem Rev 94:727–735
Solomon EI, Sundaram UM, Machonkin TE (1996) Chem Rev 96:2563–2605
Solomon EI, Chen P, Metz M, Lee S-K, Palmer AE (2001) Angew Chem Int Ed Engl 40:4570–4590
Messerschmidt A (ed) (1997) Multi-copper oxidases. World Scientific, Singapore
Lieberman RL, Rosenzweig AC (2005) Dalton Trans 3390–3396
Sánchez-Ferrer A, Rodríguez-López JN, García-Cánovas F, García-Carmona F (1995) Biochim Biophys Acta 1247:1–11
Schindler S (2000) Eur J Inorg Chem 2311–2326
Itoh S (2004) In: McCleverty JA, Meyer TJ (eds) Comprehensive coordination chemistry II, vol 8. Elsevier, Amsterdam, pp 369–393
Hatcher L, Karlin KD (2004) J Biol Inorg Chem 9:669–683
Jacobson RR, Tyeklár Z, Farooq A, Karlin KD, Liu S, Zubieta J (1988) J Am Chem Soc 110:3690–3692
Kitajima N, Fujisawa K, Moro-oka Y (1989) J Am Chem Soc 111:8975–8976
Tolman WB (1997) Acc Chem Res 30:227–237
Halfen JA, Mahapatra S, Wilkinson EC, Kaderli S, Young VG Jr, Que L Jr, Zuberbühler AD, Tolman WB (1996) Science 271:1397–1400
Decker H, Dillinger R, Tuczek F (2000) Angew Chem Int Ed Engl 39:1591–1595
Pidcock E, Obias HV, Zhang CX, Karlin KD, Solomon EI (1998) J Am Chem Soc 120:7841–7847 and references cited therein
Palavicini S, Granata A, Monzani E, Casella L (2005) J Am Chem Soc 127:18031–18036
Holland PL, Rodgers KR, Tolman WB (1999) Angew Chem Int Ed Engl 38:1139–1142
Holland PL, Tolman WB (1999) Coord Chem Rev 190–192:855–869
Siegbahn PEM (2003) J Biol Inorg Chem 8:567–576
Rode MF, Werner H-J (2005) Theor Chem Acc 114:309–317
Cramer CJ, Wloch M, Piecuch P, Puzzarini C, Gagliardi L (2006) J Phys Chem (in press)
Mirica LM, Vance M, Rudd DJ, Hedman B, Hodgson KO, Solomon EI, Stack TDP (2005) Science 308:1890–1892
Klinman JP (1996) Chem Rev 96:2541–2561
Halcrow MA (2004) In: McCleverty JA, Meyer TJ (eds) Comprehensive coordination chemistry II. Elsevier, Amsterdam, pp 395–436
Stewart LC, Klinman JP (1988) Annu Rev Biochem 57:551–592
Prigge ST, Mains RE, Eipper BA, Amzel LM (2000) Cell Mol Life Sci 57:1236–1259
Evans JP, Ahn K, Klinman JP (2003) J Biol Chem 278:49691–49698
Chen P, Solomon EI (2004) J Am Chem Soc 126:4991–5000
Prigge ST, Eipper BA, Mains RE, Amzel LM (2004) Science 304:864–867
Fujisawa K, Tanaka M, Moro-oka Y, Kitajima N (1994) J Am Chem Soc 116:12079–12080
Chen P, Root DE, Campochiaro C, Fujisawa K, Solomon EI (2003) J Am Chem Soc 125:466–474
Cramer CJ, Tolman WB, Theopold KH, Rheingold AL (2003) Proc Natl Acad Sci USA 100:3635
Spencer DJE, Aboelella NW, Reynolds AM, Holland PL, Tolman WB (2002) J Am Chem Soc 124:2108–2809
Spencer DJE, Reynolds AM, Holland PL, Jazdzewski BA, Duboc-Toia C, Pape LL, Yokota S, Tachi Y, Itoh S, Tolman WB (2002) Inorg Chem 41:6307–6321
Aboelella NW, Lewis EA, Reynolds AM, Brennessel WW, Cramer CJ, Tolman WB (2002) J Am Chem Soc 124:10660–10661
Aboelella NW, Kryatov SV, Gherman BF, Brennessel WW, Young VG Jr, Sarangi R, Rybak-Akimova EV, Hodgson KO, Hedman B, Solomon EI, Cramer CJ, Tolman WB (2004) J Am Chem Soc 126:16896–16911
Reynolds AM, Gherman BF, Cramer CJ, Tolman WB (2005) Inorg Chem 44:6989–6997
Gherman BF, Cramer CJ (2004) Inorg Chem 43:7281–7283
Aboelella NW, York JT, Reynolds AM, Fujita K, Kinsinger CR, Cramer CJ, Riordan CG, Tolman WB (2004) Chem Commun 1716–1717
Aboelella NW, Gherman BF, Hill LMR, York JT, Holm N, Young VG Jr, Cramer CJ, Tolman WB (2006) J Am Chem Soc (accepted)
Acknowledgements
I am grateful for the hard work and dedication of all of my current and former coworkers at the University of Minnesota, whose names are cited in the references. I also thank my collaborators, in particular E.I. Solomon (advanced spectroscopy), E. Rybak-Akimova and A. Zuberbühler (cryogenic stopped-flow kinetics), and C. Cramer (theory) for their extensive contributions and insights. The Cu bioinorganic chemistry research performed in my group is supported by the NIH (GM47365).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tolman, W.B. Using synthetic chemistry to understand copper protein active sites: a personal perspective. J Biol Inorg Chem 11, 261–271 (2006). https://doi.org/10.1007/s00775-006-0078-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00775-006-0078-9